Showing results (661-670 of 835) with videos related to
Sort By:
Pageof 84
Pediatric Blood & Cancer|April 26, 2007
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.Nature Structural & Molecular Biology|February 22, 2023
Modeling HIV-1 nuclear entry with nucleoporin-gated DNA-origami channelsQi Shen, Qingzhou Feng, Chunxiang Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.Genes, Chromosomes & Cancer|December 22, 2022
Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progressionKevin Stachelek, Narine Harutyunyan, Susan Lee, et al.Pediatric Blood & Cancer|October 5, 2007
Initial testing of dasatinib by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.Pediatric Blood & Cancer|July 9, 2015
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastomaClarke P Anderson, Katherine K Matthay, John P Perentesis, et al.Blood Advances|June 20, 2020
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic painAmanda M Brandow, C Patrick Carroll, Susan Creary, et al.Blood|May 16, 2000
Hepatitis C infection among survivors of childhood cancerD K Strickland, C A Riely, C C Patrick, et al.American Journal of Hematology|September 2, 2022
Converting adults with sickle cell disease from full agonist opioids to buprenorphine: A reliable method with safety and early evidence of reduced acute care utilizationMandy S David, Jennifer Jones, Ashley Lauriello, et al.Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.Pageof 84